Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17416381 | 0.92 | TTK (0.63) | TTKCYP3A4 | |
| SCHEMBL17416361 | 0.91 | TTK (0.61) | TTKCYP3A4 | |
| SCHEMBL462358 | 0.91 | TTK (0.67) | TTKCYP3A4 | |
| SCHEMBL456090 | 0.90 | TTK (0.76) | TTK | |
| SCHEMBL15555488 | 0.89 | TTK (0.63) | TTKCYP3A4 | |
| SCHEMBL456967 | 0.89 | TTK (0.63) | TTKCYP3A4 | |
| SCHEMBL10279713 | 0.89 | TTK (0.64) | TTKCYP3A4 | |
| SCHEMBL456052 | 0.89 | TTK (0.64) | TTKCYP3A4 | |
| SCHEMBL470159 | 0.89 | TTK (0.59) | TTKCYP3A4 | |
| SCHEMBL10279543 | 0.88 | TTK (0.65) | TTKCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2614063-B1 | SUBSTITUTED IMIDAZOPYRIDAZINES | BAYER IP GMBH (DE) | 2016-01-13 | — | — | EP | claimed |
| WO-2014020041-A1 | COMBINATIONS FOR THE TREATMENT OF CANCER | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2014-02-06 | — | — | WO | claimed |
| EP-2614063-B1 | SUBSTITUTED IMIDAZOPYRIDAZINES | BAYER IP GMBH (DE) | 2016-01-13 | — | — | EP | disclosed |
| EP-2614063-B1 | SUBSTITUTED IMIDAZOPYRIDAZINES | BAYER IP GMBH (DE) | 2016-01-13 | — | — | EP | disclosed |
| EP-2614063-A1 | SUBSTITUTED IMIDAZOPYRIDAZINES | Bayer Intellectual Property GmbH (DE) | 2013-07-17 | — | — | EP | disclosed |
| WO-2012032031-A1 | SUBSTITUTED IMIDAZOPYRIDAZINES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-03-15 | — | — | WO | disclosed |